definiens: or and or ( as such terms are defined in 38 U.S.C. § 8126(h)(5 ) and anyapplicable agreement between a pharmaceutical manufacturer and the U.S. Department of VeteransAffairs to implement the provisions of the Veterans Health Care Act of 1992, 38 U.S.C. § 8126, or the ), including : ( A ) with respect to AMP, ASP, and Best Price, ( I ) calendar quarter in whichbaseline AMP was established, ( II ) baseline AMP, ( III ) all other baseline Product informationsubmitted by Seller to the CMS in connection with the Medicaid drug rebate program ( including unitsper package size, market start date, etc . ), and ( IV ) transactional data reasonably necessary forPurchaser to calculate AMP, ASP, and Best Price for the quarters and months ( as applicable)beginning with the AMP, ASP, and Best Price submissions due on or after the Closing Date ; 34 ( B ) with respect to the U.S. Public Health Service 340B Drug PricingProgram created under Section 340B of the Public Health Service Act and Section 602 of theVeterans Health Care Act of 1992 ( the ), the PHS Program price for the calendarquarter in which the Closing Date occurs and one subsequent calendar quarter ; and ( C ) with respect to the Veterans Health Care Act of 1992, ( I ) the applicable or ( as such figure is calculated pursuant to 38 U.S.C. § 8126(a ) and theVA Master Agreement ), ( II ) the Non - FAMP calculations for each calendar quarter of 2019, ( III ) anycommercial sales data reasonably necessary to perform quarterly and annual Non - FAMPcalculations, and ( IV ) any price lists applicable for purposes of sales under any applicable contractwith the U.S. Department of Veterans Affairs under Federal Supply Schedule 65IB for Drugs, Pharmaceuticals, & Hematology Related Products